Antimicrobial Resistance Patterns of Staphylococcus aureus in a Pediatric Population: A Cross-Sectional Analysis of Demographic, Clinical, and Laboratory Correlates in Qom, Iran (2019–2020)
Article Sidebar
Main Article Content
Abstract
Background: Staphylococcus aureu resistance poses a critical threat to pediatric care. We aimed to comprehensively evaluate S. aureus resistance patterns and their associations with demographic (age, sex, ethnicity), clinical (disease severity, sampling site), and laboratory parameters (WBC, CRP) in a pediatric referral center in Qom, Iran.
Methods: A retrospective cross-sectional study (Mar 2019–Mar 2020) used medical records of patients under 15. Clinical samples were cultured on blood and mannitol salt agar; S. aureus was identified via catalase/coagulase tests. Antibiotic resistance was assessed by disk diffusion. Of 24,342 specimens from hospitalized and outpatient children, 216 tested positive for S. aureus.
Results: Among 216 isolates (120 males, 96 females; 167 Iranian, 37 Afghan, 12 Iraqi), 92 were from inpatients and 124 from outpatients. High resistance was seen to ampicillin (77.3%), erythromycin (65%), and cefixime (62.5%). Resistance to meropenem (43%) and vancomycin (12%; including 8.3% MRSA) was concerning. Multidrug resistance (≥3 classes) appeared in 22.7%. Lowest resistance was to imipenem (0%), co-amoxiclav (3%), and amikacin (6%). Complete resistance to cefepime, nalidixic acid, and nitrofurantoin was seen in a few samples (n≤10), possibly due to sampling bias.
Conclusion: The study reveals emerging resistance to newer antibiotics, including vancomycin and meropenem, highlighting the need for region-specific stewardship and better surveillance to combat antimicrobial-resistant S. aureus in pediatric populations.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Rasigade J-P, Vandenesch F. Staphylococcus aureus: a pathogen with still unresolved issues. Infect Genet Evol. 2014;21:510-4.
Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler Jr VG. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603-61.
Klieger SB, Vendetti ND, Fisher BT, Gerber JS. Staphylococcus aureus bacteremia in hospitalized children: incidence and outcomes. Infect Control Hosp Epidemiol. 2015;36(5):603-5.
Thorburn K, Taylor N, Saladi S, van Saene H. Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit. Clin Microbiol Infect. 2006;12(1):35-42.
Roberts I. Nelson’s textbook of pediatrics (20th edn.), by R. Kliegman, B. Stanton, J. St. Geme, N. Schor (eds) Elsevier, Philadelphia, 2016, Hardcover (2 volumes) 3,888 pp., English, ISBN 978-1-4557-7566-8 (International edition also available) includes access to the e-book version, US $221, UK£ 108.99. Springer; 2017.
Kirby WM. Extraction of a highly potent penicillin inactivator from penicillin resistant staphylococci. Science. 1944;99(2579):452-3.
Boyle-Vavra S, Daum RS. Molecular strategies of Staphylococcus aureus for resisting antibiotics. 2016.
Tomasz A. The mechanism of the irreversible antimicrobial effects of penicillins: how the beta-lactam antibiotics kill and lyse bacteria. Ann Rev Microbiol. 1979;33(1):113-37.
Johnson AP. Methicillin-resistant Staphylococcus aureus: the European landscape. J Antimicrob Chemother. 2011;66(suppl_4):iv43-iv8.
Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36(1):53-9.
Meatherall BL, Gregson D, Ross T, Pitout JD, Laupland KB. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia. Am J Med. 2009;122(9):866-73.
de Benito S, Alou L, Becerro-de-Bengoa-Vallejo R, Losa-Iglesias ME, Gómez-Lus ML, Collado L, et al. Prevalence of Staphylococcus spp. nasal colonization among doctors of podiatric medicine and associated risk factors in Spain. Antimicrob Resist Infect Control. 2018;7:1-7.
TAVARES DA, et al. Large screening of CA-MRSA among Staphylococcus aureus colonizing healthy young children living in two areas (urban and rural) of Portugal. . BMC Infect Dis. 2010;10:1-8..
Tabatabaei SM, Salimi Khorashad A. Antimicrobial resistance patterns of Vibrio cholera strains isolated from Afghan and Iranian patients in Iran. Int J Infect. 2015;2(1):e22822.
Nazari J, Chezani-Sharahi N, Naghshbandi M, Karimi Y, Moradzadeh R. Prevalence of Antibiotics Consumption in Children in Central Iran: 2019-2020. Iran J Toxicol. 2023;17(3):36-42.
Abbasian H, Hajimolaali M, Yektadoost A, Zartab S. Antibiotic Utilization in Iran 2000-2016: Pattern Analysis and Benchmarking with Organization for Economic Co-operation and Development Countries. J Res Pharm Pract. 2019;8(3):162-7.
Krishnan S, Setty Y, Betal SG, Vijender V, Rao K, Dampier C, et al. Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises. Br J Haematol. 2010;148(5):797-804.
Hindler JA W-BA, Charlton CL, Miller SA, Kelesidis T, Carvalho M, et al. . Analysis of vancomycin population susceptibility profiles, MIC creep, and resistance in Staphylococcus aureus. J Clin Microbiol 2018;56(4):e01636-17.
NABOVATI, Ehsan, et al. Antibiotic prescribing in inpatient and outpatient settings in Iran: a systematic review and meta-analysis study. Antimicrobial Resistance & Infection Control, 2021, 10.1: 15.
Tsering DC PR, Kar S. . Methicillin-resistant Staphylococcus aureus: prevalence and current susceptibility pattern in Sikkim. . J Glob Infect Dis. 2011;3(1):9-13.
Schaad UB SS, Gianella-Borradori A, Pfenninger J, Auckenthaler R, Bernath O, et al. . A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. N Engl J Med 1990;322(3):141-7.
Azimi T MS, Fallah F, Azimi L, Gholinejad Z. . Evaluating the antimicrobial resistance patterns among major bacterial pathogens isolated from clinical specimens taken from patients in Mofid Children's Hospital, Tehran, Iran: 2013-2018. Infect Drug Resist. 2019;12:2089-102.
Lessa de Menezes I MPS, da Silva Pone MV. Clinical, . demographic characteristics and antimicrobial resistance profile of Staphylococcus aureus isolated in clinical samples from pediatric patients in a tertiary hospital in Rio de Janeiro: 7-year longitudinal study. BMC Infect Dis 2024;24(1):1081.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 33rd ed. CLSI supplement M100. Wayne PC.